IC

ICU Medical IncFRA ICU Stock Report

Last reporting period 30 Jun, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

4.338

Middle

Exchange

XFRA - Deutsche Boerse AG

IC7.F Stock Analysis

IC

Uncovered

ICU Medical Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

3/100

Low score

Market cap $B

4.338

Dividend yield

Shares outstanding

23.998 B

ICU Medical, Inc. develops, manufactures and sells medical products used in infusion therapy, vascular access, and vital care applications. The Company’s product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its primary Infusion System products are dedicated IV sets and others. Its primary IV Solutions products include IV Therapy and Diluents and Irrigation. Its primary Critical Care products include Cogent 2-in-1 hemodynamic monitoring system; CardioFlo hemodynamic monitoring system; TDQ and OptiQ cardiac output monitoring catheters; TriOxTM venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation system.

View Section: Eyestock Rating